カテゴリ： Market Monitor Global, 世界, 部品/材料

医薬品用カンナビスのグローバル市場展望 2023年-2029年：ドロナビノール、ナビロン、ナビキシモールズ、カンナビジオール、その他

■ 英語タイトル：Pharmaceutical Grade Cannabis Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU2201）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU2201
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：化学＆材料
■ ページ数：123
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[医薬品用カンナビスのグローバル市場展望 2023年-2029年：ドロナビノール、ナビロン、ナビキシモールズ、カンナビジオール、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の医薬品用カンナビス市場規模と予測を収録しています。・世界の医薬品用カンナビス市場：売上、2018年-2023年、2024年-2029年
・世界の医薬品用カンナビス市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の医薬品用カンナビス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ドロナビノール」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

医薬品用カンナビスのグローバル主要企業は、Ultra Health、 Mammoth Farms、 Palo Verde Center、 Hexo Corp、 Bright Green Corporation、 Copperstate Farms、 Los Suenos Farms、 Canna、 Village Farms、 Aurora、 Canopy Growth、 Cresco Labs、 Glass House Farms、 Organigram、 C3 International、 CannTrust、 FlowerOne、 Solaris Farms、 7Acres、 ThePharmなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、医薬品用カンナビスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の医薬品用カンナビス市場：タイプ別、2018年-2023年、2024年-2029年
世界の医薬品用カンナビス市場：タイプ別市場シェア、2022年
・ドロナビノール、ナビロン、ナビキシモールズ、カンナビジオール、その他

世界の医薬品用カンナビス市場：用途別、2018年-2023年、2024年-2029年
世界の医薬品用カンナビス市場：用途別市場シェア、2022年
・内服薬、外用薬

世界の医薬品用カンナビス市場：地域・国別、2018年-2023年、2024年-2029年
世界の医薬品用カンナビス市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における医薬品用カンナビスのグローバル売上、2018年-2023年
・主要企業における医薬品用カンナビスのグローバル売上シェア、2022年
・主要企業における医薬品用カンナビスのグローバル販売量、2018年-2023年
・主要企業における医薬品用カンナビスのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Ultra Health、 Mammoth Farms、 Palo Verde Center、 Hexo Corp、 Bright Green Corporation、 Copperstate Farms、 Los Suenos Farms、 Canna、 Village Farms、 Aurora、 Canopy Growth、 Cresco Labs、 Glass House Farms、 Organigram、 C3 International、 CannTrust、 FlowerOne、 Solaris Farms、 7Acres、 ThePharm

*************************************************************

・調査・分析レポートの概要
医薬品用カンナビス市場の定義
市場セグメント
世界の医薬品用カンナビス市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の医薬品用カンナビス市場規模
世界の医薬品用カンナビス市場規模：2022年 VS 2029年
世界の医薬品用カンナビス市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの医薬品用カンナビスの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の医薬品用カンナビス製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ドロナビノール、ナビロン、ナビキシモールズ、カンナビジオール、その他
医薬品用カンナビスのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：内服薬、外用薬
医薬品用カンナビスの用途別グローバル売上・予測

・地域別市場分析
地域別医薬品用カンナビス市場規模 2022年と2029年
地域別医薬品用カンナビス売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Ultra Health、 Mammoth Farms、 Palo Verde Center、 Hexo Corp、 Bright Green Corporation、 Copperstate Farms、 Los Suenos Farms、 Canna、 Village Farms、 Aurora、 Canopy Growth、 Cresco Labs、 Glass House Farms、 Organigram、 C3 International、 CannTrust、 FlowerOne、 Solaris Farms、 7Acres、 ThePharm
...

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Cannabis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Cannabis. This report contains market size and forecasts of Pharmaceutical Grade Cannabis in global, including the following market information:
Global Pharmaceutical Grade Cannabis Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pharmaceutical Grade Cannabis Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Pharmaceutical Grade Cannabis companies in 2022 (%)
The global Pharmaceutical Grade Cannabis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Dronabinol Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical Grade Cannabis include Ultra Health, Mammoth Farms, Palo Verde Center, Hexo Corp, Bright Green Corporation, Copperstate Farms, Los Suenos Farms, Canna and Village Farms, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical Grade Cannabis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical Grade Cannabis Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Pharmaceutical Grade Cannabis Market Segment Percentages, by Type, 2022 (%)
Dronabinol
Nabilone
Nabiximols
Cannabidiol
Other
Global Pharmaceutical Grade Cannabis Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Pharmaceutical Grade Cannabis Market Segment Percentages, by Application, 2022 (%)
Oral Medications
Topical Medications
Global Pharmaceutical Grade Cannabis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Pharmaceutical Grade Cannabis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical Grade Cannabis revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pharmaceutical Grade Cannabis revenues share in global market, 2022 (%)
Key companies Pharmaceutical Grade Cannabis sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Pharmaceutical Grade Cannabis sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ultra Health
Mammoth Farms
Palo Verde Center
Hexo Corp
Bright Green Corporation
Copperstate Farms
Los Suenos Farms
Canna
Village Farms
Aurora
Canopy Growth
Cresco Labs
Glass House Farms
Organigram
C3 International
CannTrust
FlowerOne
Solaris Farms
7Acres
ThePharm
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical Grade Cannabis, market overview.
Chapter 2: Global Pharmaceutical Grade Cannabis market size in revenue and volume.
Chapter 3: Detailed analysis of Pharmaceutical Grade Cannabis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Grade Cannabis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pharmaceutical Grade Cannabis capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Pharmaceutical Grade Cannabis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutical Grade Cannabis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutical Grade Cannabis Overall Market Size
2.1 Global Pharmaceutical Grade Cannabis Market Size: 2022 VS 2029
2.2 Global Pharmaceutical Grade Cannabis Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pharmaceutical Grade Cannabis Sales: 2018-2029
3 Company Landscape
3.1 Top Pharmaceutical Grade Cannabis Players in Global Market
3.2 Top Global Pharmaceutical Grade Cannabis Companies Ranked by Revenue
3.3 Global Pharmaceutical Grade Cannabis Revenue by Companies
3.4 Global Pharmaceutical Grade Cannabis Sales by Companies
3.5 Global Pharmaceutical Grade Cannabis Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pharmaceutical Grade Cannabis Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pharmaceutical Grade Cannabis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pharmaceutical Grade Cannabis Players in Global Market
3.8.1 List of Global Tier 1 Pharmaceutical Grade Cannabis Companies
3.8.2 List of Global Tier 2 and Tier 3 Pharmaceutical Grade Cannabis Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Pharmaceutical Grade Cannabis Market Size Markets, 2022 & 2029
4.1.2 Dronabinol
4.1.3 Nabilone
4.1.4 Nabiximols
4.1.5 Cannabidiol
4.1.6 Other
4.2 By Type – Global Pharmaceutical Grade Cannabis Revenue & Forecasts
4.2.1 By Type – Global Pharmaceutical Grade Cannabis Revenue, 2018-2023
4.2.2 By Type – Global Pharmaceutical Grade Cannabis Revenue, 2024-2029
4.2.3 By Type – Global Pharmaceutical Grade Cannabis Revenue Market Share, 2018-2029
4.3 By Type – Global Pharmaceutical Grade Cannabis Sales & Forecasts
4.3.1 By Type – Global Pharmaceutical Grade Cannabis Sales, 2018-2023
4.3.2 By Type – Global Pharmaceutical Grade Cannabis Sales, 2024-2029
4.3.3 By Type – Global Pharmaceutical Grade Cannabis Sales Market Share, 2018-2029
4.4 By Type – Global Pharmaceutical Grade Cannabis Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pharmaceutical Grade Cannabis Market Size, 2022 & 2029
5.1.2 Oral Medications
5.1.3 Topical Medications
5.2 By Application – Global Pharmaceutical Grade Cannabis Revenue & Forecasts
5.2.1 By Application – Global Pharmaceutical Grade Cannabis Revenue, 2018-2023
5.2.2 By Application – Global Pharmaceutical Grade Cannabis Revenue, 2024-2029
5.2.3 By Application – Global Pharmaceutical Grade Cannabis Revenue Market Share, 2018-2029
5.3 By Application – Global Pharmaceutical Grade Cannabis Sales & Forecasts
5.3.1 By Application – Global Pharmaceutical Grade Cannabis Sales, 2018-2023
5.3.2 By Application – Global Pharmaceutical Grade Cannabis Sales, 2024-2029
5.3.3 By Application – Global Pharmaceutical Grade Cannabis Sales Market Share, 2018-2029
5.4 By Application – Global Pharmaceutical Grade Cannabis Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Pharmaceutical Grade Cannabis Market Size, 2022 & 2029
6.2 By Region – Global Pharmaceutical Grade Cannabis Revenue & Forecasts
6.2.1 By Region – Global Pharmaceutical Grade Cannabis Revenue, 2018-2023
6.2.2 By Region – Global Pharmaceutical Grade Cannabis Revenue, 2024-2029
6.2.3 By Region – Global Pharmaceutical Grade Cannabis Revenue Market Share, 2018-2029
6.3 By Region – Global Pharmaceutical Grade Cannabis Sales & Forecasts
6.3.1 By Region – Global Pharmaceutical Grade Cannabis Sales, 2018-2023
6.3.2 By Region – Global Pharmaceutical Grade Cannabis Sales, 2024-2029
6.3.3 By Region – Global Pharmaceutical Grade Cannabis Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Pharmaceutical Grade Cannabis Revenue, 2018-2029
6.4.2 By Country – North America Pharmaceutical Grade Cannabis Sales, 2018-2029
6.4.3 US Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.4.4 Canada Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.4.5 Mexico Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Pharmaceutical Grade Cannabis Revenue, 2018-2029
6.5.2 By Country – Europe Pharmaceutical Grade Cannabis Sales, 2018-2029
6.5.3 Germany Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.5.4 France Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.5.5 U.K. Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.5.6 Italy Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.5.7 Russia Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.5.8 Nordic Countries Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.5.9 Benelux Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Pharmaceutical Grade Cannabis Revenue, 2018-2029
6.6.2 By Region – Asia Pharmaceutical Grade Cannabis Sales, 2018-2029
6.6.3 China Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.6.4 Japan Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.6.5 South Korea Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.6.6 Southeast Asia Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.6.7 India Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Pharmaceutical Grade Cannabis Revenue, 2018-2029
6.7.2 By Country – South America Pharmaceutical Grade Cannabis Sales, 2018-2029
6.7.3 Brazil Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.7.4 Argentina Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Pharmaceutical Grade Cannabis Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Pharmaceutical Grade Cannabis Sales, 2018-2029
6.8.3 Turkey Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.8.4 Israel Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.8.5 Saudi Arabia Pharmaceutical Grade Cannabis Market Size, 2018-2029
6.8.6 UAE Pharmaceutical Grade Cannabis Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Ultra Health
7.1.1 Ultra Health Company Summary
7.1.2 Ultra Health Business Overview
7.1.3 Ultra Health Pharmaceutical Grade Cannabis Major Product Offerings
7.1.4 Ultra Health Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.1.5 Ultra Health Key News & Latest Developments
7.2 Mammoth Farms
7.2.1 Mammoth Farms Company Summary
7.2.2 Mammoth Farms Business Overview
7.2.3 Mammoth Farms Pharmaceutical Grade Cannabis Major Product Offerings
7.2.4 Mammoth Farms Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.2.5 Mammoth Farms Key News & Latest Developments
7.3 Palo Verde Center
7.3.1 Palo Verde Center Company Summary
7.3.2 Palo Verde Center Business Overview
7.3.3 Palo Verde Center Pharmaceutical Grade Cannabis Major Product Offerings
7.3.4 Palo Verde Center Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.3.5 Palo Verde Center Key News & Latest Developments
7.4 Hexo Corp
7.4.1 Hexo Corp Company Summary
7.4.2 Hexo Corp Business Overview
7.4.3 Hexo Corp Pharmaceutical Grade Cannabis Major Product Offerings
7.4.4 Hexo Corp Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.4.5 Hexo Corp Key News & Latest Developments
7.5 Bright Green Corporation
7.5.1 Bright Green Corporation Company Summary
7.5.2 Bright Green Corporation Business Overview
7.5.3 Bright Green Corporation Pharmaceutical Grade Cannabis Major Product Offerings
7.5.4 Bright Green Corporation Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.5.5 Bright Green Corporation Key News & Latest Developments
7.6 Copperstate Farms
7.6.1 Copperstate Farms Company Summary
7.6.2 Copperstate Farms Business Overview
7.6.3 Copperstate Farms Pharmaceutical Grade Cannabis Major Product Offerings
7.6.4 Copperstate Farms Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.6.5 Copperstate Farms Key News & Latest Developments
7.7 Los Suenos Farms
7.7.1 Los Suenos Farms Company Summary
7.7.2 Los Suenos Farms Business Overview
7.7.3 Los Suenos Farms Pharmaceutical Grade Cannabis Major Product Offerings
7.7.4 Los Suenos Farms Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.7.5 Los Suenos Farms Key News & Latest Developments
7.8 Canna
7.8.1 Canna Company Summary
7.8.2 Canna Business Overview
7.8.3 Canna Pharmaceutical Grade Cannabis Major Product Offerings
7.8.4 Canna Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.8.5 Canna Key News & Latest Developments
7.9 Village Farms
7.9.1 Village Farms Company Summary
7.9.2 Village Farms Business Overview
7.9.3 Village Farms Pharmaceutical Grade Cannabis Major Product Offerings
7.9.4 Village Farms Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.9.5 Village Farms Key News & Latest Developments
7.10 Aurora
7.10.1 Aurora Company Summary
7.10.2 Aurora Business Overview
7.10.3 Aurora Pharmaceutical Grade Cannabis Major Product Offerings
7.10.4 Aurora Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.10.5 Aurora Key News & Latest Developments
7.11 Canopy Growth
7.11.1 Canopy Growth Company Summary
7.11.2 Canopy Growth Pharmaceutical Grade Cannabis Business Overview
7.11.3 Canopy Growth Pharmaceutical Grade Cannabis Major Product Offerings
7.11.4 Canopy Growth Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.11.5 Canopy Growth Key News & Latest Developments
7.12 Cresco Labs
7.12.1 Cresco Labs Company Summary
7.12.2 Cresco Labs Pharmaceutical Grade Cannabis Business Overview
7.12.3 Cresco Labs Pharmaceutical Grade Cannabis Major Product Offerings
7.12.4 Cresco Labs Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.12.5 Cresco Labs Key News & Latest Developments
7.13 Glass House Farms
7.13.1 Glass House Farms Company Summary
7.13.2 Glass House Farms Pharmaceutical Grade Cannabis Business Overview
7.13.3 Glass House Farms Pharmaceutical Grade Cannabis Major Product Offerings
7.13.4 Glass House Farms Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.13.5 Glass House Farms Key News & Latest Developments
7.14 Organigram
7.14.1 Organigram Company Summary
7.14.2 Organigram Business Overview
7.14.3 Organigram Pharmaceutical Grade Cannabis Major Product Offerings
7.14.4 Organigram Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.14.5 Organigram Key News & Latest Developments
7.15 C3 International
7.15.1 C3 International Company Summary
7.15.2 C3 International Business Overview
7.15.3 C3 International Pharmaceutical Grade Cannabis Major Product Offerings
7.15.4 C3 International Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.15.5 C3 International Key News & Latest Developments
7.16 CannTrust
7.16.1 CannTrust Company Summary
7.16.2 CannTrust Business Overview
7.16.3 CannTrust Pharmaceutical Grade Cannabis Major Product Offerings
7.16.4 CannTrust Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.16.5 CannTrust Key News & Latest Developments
7.17 FlowerOne
7.17.1 FlowerOne Company Summary
7.17.2 FlowerOne Business Overview
7.17.3 FlowerOne Pharmaceutical Grade Cannabis Major Product Offerings
7.17.4 FlowerOne Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.17.5 FlowerOne Key News & Latest Developments
7.18 Solaris Farms
7.18.1 Solaris Farms Company Summary
7.18.2 Solaris Farms Business Overview
7.18.3 Solaris Farms Pharmaceutical Grade Cannabis Major Product Offerings
7.18.4 Solaris Farms Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.18.5 Solaris Farms Key News & Latest Developments
7.19 7Acres
7.19.1 7Acres Company Summary
7.19.2 7Acres Business Overview
7.19.3 7Acres Pharmaceutical Grade Cannabis Major Product Offerings
7.19.4 7Acres Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.19.5 7Acres Key News & Latest Developments
7.20 ThePharm
7.20.1 ThePharm Company Summary
7.20.2 ThePharm Business Overview
7.20.3 ThePharm Pharmaceutical Grade Cannabis Major Product Offerings
7.20.4 ThePharm Pharmaceutical Grade Cannabis Sales and Revenue in Global (2018-2023)
7.20.5 ThePharm Key News & Latest Developments
8 Global Pharmaceutical Grade Cannabis Production Capacity, Analysis
8.1 Global Pharmaceutical Grade Cannabis Production Capacity, 2018-2029
8.2 Pharmaceutical Grade Cannabis Production Capacity of Key Manufacturers in Global Market
8.3 Global Pharmaceutical Grade Cannabis Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pharmaceutical Grade Cannabis Supply Chain Analysis
10.1 Pharmaceutical Grade Cannabis Industry Value Chain
10.2 Pharmaceutical Grade Cannabis Upstream Market
10.3 Pharmaceutical Grade Cannabis Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pharmaceutical Grade Cannabis Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 大麻飲料のグローバル市場（～2027）：アルコール、カンナビジオール（CBD）、ノンアルコール、テトラヒドロカンナビノール（THC）
  • CBD（カンナビジオール）のグローバル市場：固体、液体
  • 世界の医療用大麻市場予測2024年-2032年：品種別（インディカ、サティバ、ハイブリッド）、誘導体別（カンナビジオール（CBD）、テトラヒドロカンナビノール（THC）、その他）、用途別（癌、関節炎、片頭痛、てんかん、その他）、最終用途別（製薬産業、研究開発センター、その他）、投与経路別（内服液・カプセル、気化器、外用剤、その他）、地域別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU2201 )"医薬品用カンナビスのグローバル市場展望 2023年-2029年：ドロナビノール、ナビロン、ナビキシモールズ、カンナビジオール、その他" (英文：Pharmaceutical Grade Cannabis Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。